Literature DB >> 6137055

Neurotransmission in activation of the contractile response in the human urinary bladder.

A Nergårdh, A C Kinn.   

Abstract

The endogenous contracting transmitter at the neuromuscular junction in strips from human urinary bladder has been investigated using field stimulation and selective antagonists. Atropine in low concentrations was found to inhibit bladder contractions whereas higher concentrations of the drug sometimes had the opposite effects. Indomethacin inhibited, phentolamine enhanced and methysergide had no dose-dependent effect on the field stimulation response. It is proposed that acetylcholine is one of the transmitter substances responsible for the contraction of the human detrusor. Species differences which could be responsible for the alleged atropine-resistance of the bladder are discussed. It is concluded that anticholinergic drugs should be of therapeutic value for treatment of muscular hyperactivity in the human urinary bladder.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6137055     DOI: 10.3109/00365598309180160

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  6 in total

Review 1.  Non-adrenergic, non-cholinergic control of the urinary bladder.

Authors:  C H Hoyle
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

2.  Inhibitory effect of streptozotocin-induced diabetes on non-cholinergic motor transmission in rat detrusor and its prevention by sorbinil.

Authors:  G N Luheshi; M A Zar
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

3.  Alpha-adrenoceptor function before and after chemical sympathectomy in human and feline detrusor muscles.

Authors:  P Amark; L Olson
Journal:  Urol Res       Date:  1992

4.  A comparison of spontaneous and nerve-mediated activity in bladder muscle from man, pig and rabbit.

Authors:  G N Sibley
Journal:  J Physiol       Date:  1984-09       Impact factor: 5.182

Review 5.  Purinergic signalling in the urinary tract in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

Review 6.  Purinoceptors as therapeutic targets for lower urinary tract dysfunction.

Authors:  Anthony P D W Ford; Joel R Gever; Philip A Nunn; Yu Zhong; Joseph S Cefalu; Michael P Dillon; Debra A Cockayne
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.